Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression

Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients

Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenoviruses

Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells

Dendritic cell immunotherapy for stage IV melanoma

Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes

Review: dendritic cell-based vaccine in the treatment of patients with advanced melanoma

Benefits of superficial hyperthermia treatment planning: five case studies